Evaluation of the relationship between serum ferritin and insulin resistance and visceral adiposity index (VAI) in women with polycystic ovary syndrome
- PMID: 32772321
- DOI: 10.1007/s40519-020-00980-x
Evaluation of the relationship between serum ferritin and insulin resistance and visceral adiposity index (VAI) in women with polycystic ovary syndrome
Abstract
Purpose: There is a relationship between polycystic ovary syndrome (PCOS) and adipose tissue dysfunction (ADD), but this relationship is not clear. It has been recently shown that iron accumulation in adipose tissue is among the causes of adipose tissue dysfunction. Data on adipose tissue dysfunction in women with PCOS are insufficient. In this study, we aimed to evaluate the relationship between serum ferritin levels (iron accumulation biomarker) and visceral adiposity index (an indicator of adipose tissue dysfunction).
Methods: The study is a case-control study. Women with diagnosed PCOS with 2003 Rotterdam Diagnostic Criteria (n = 40) were compared with non-PCOS group (n = 40). In this study, the cholesterol ratios, the homeostatic model evaluation index for insulin resistance (HOMA-IR) and the quantitative insulin sensitivity control index were calculated using biochemical parameters, and the visceral adiposity index (VAI) and the lipid accumulation product (LAP) were calculated using both anthropometric and biochemical parameters. In this study, insulin resistance was evaluated by HOMA-IR and adipose tissue dysfunction was evaluated by VAI index.
Results: According to the results of this study, women with PCOS have a worse metabolic status than women without PCOS. However, this has been shown only in overweight and obese women, not in women with normal weight.
Conclusion: As a result, the presence of obesity in women with PCOS exacerbates metabolic status.
Level of evidence: Level V, cross-sectional descriptive study.
Keywords: Ferritin; Insulin resistance; Obesity; Polycystic ovary syndrome; Visceral adiposity index.
Similar articles
-
Visceral and Dysfunctional Adiposity Indices as Predictors of Insulin Resistance and Metabolic Syndrome in Women with Polycystic Ovary Syndrome: A Cross-Sectional Study.Medicina (Kaunas). 2025 Feb 28;61(3):424. doi: 10.3390/medicina61030424. Medicina (Kaunas). 2025. PMID: 40142235 Free PMC article.
-
Visceral adiposity index levels in overweight and/or obese, and non-obese patients with polycystic ovary syndrome and its relationship with metabolic and inflammatory parameters.J Endocrinol Invest. 2017 May;40(5):487-497. doi: 10.1007/s40618-016-0582-x. Epub 2016 Nov 12. J Endocrinol Invest. 2017. PMID: 27838846
-
The role of the visceral adiposity index in the assessment of metabolic syndrome of polycystic ovary syndrome patients: a new anthropometric index.Arch Gynecol Obstet. 2024 Apr;309(4):1643-1649. doi: 10.1007/s00404-023-07328-7. Epub 2024 Feb 6. Arch Gynecol Obstet. 2024. PMID: 38321350
-
Visceral adiposity index as a predictor of clinical severity and therapeutic outcome of PCOS.Gynecol Endocrinol. 2016;32(3):177-83. doi: 10.3109/09513590.2015.1111327. Epub 2015 Nov 20. Gynecol Endocrinol. 2016. PMID: 26502288 Review.
-
Metabolic consequences of obesity and insulin resistance in polycystic ovary syndrome: diagnostic and methodological challenges.Nutr Res Rev. 2017 Jun;30(1):97-105. doi: 10.1017/S0954422416000287. Epub 2017 Feb 22. Nutr Res Rev. 2017. PMID: 28222828 Review.
Cited by
-
Physiological effect of iron status on patients with polycystic ovary syndrome in Basrah city.J Med Biochem. 2023 Aug 25;42(3):530-535. doi: 10.5937/jomb0-39091a. J Med Biochem. 2023. PMID: 37790203 Free PMC article.
-
Triglyceride-glucose index and lipid ratios in women with and without polycystic ovary syndrome: a systematic review and meta-analysis.Ther Adv Endocrinol Metab. 2025 Mar 31;16:20420188251328840. doi: 10.1177/20420188251328840. eCollection 2025. Ther Adv Endocrinol Metab. 2025. PMID: 40171216 Free PMC article.
-
Rhamnocitrin Attenuates Ovarian Fibrosis in Rats with Letrozole-Induced Experimental Polycystic Ovary Syndrome.Oxid Med Cell Longev. 2022 May 26;2022:5558599. doi: 10.1155/2022/5558599. eCollection 2022. Oxid Med Cell Longev. 2022. PMID: 35663203 Free PMC article.
-
A novel visceral adiposity index predicts bone loss in female early rheumatoid arthritis patients detected by HR-pQCT.Sci Rep. 2023 Feb 11;13(1):2471. doi: 10.1038/s41598-023-29505-z. Sci Rep. 2023. PMID: 36774444 Free PMC article.
-
Association between visceral adiposity index and oral health status in a National survey.Sci Rep. 2025 Jul 28;15(1):27486. doi: 10.1038/s41598-025-11803-3. Sci Rep. 2025. PMID: 40721428 Free PMC article.
References
-
- Lee I, Cooney LG, Saini S, Smith ME, Sammel MD, Allison KC, Dokras A (2017) Increased risk of disordered eating in polycystic ovary syndrome. Fertil Steril 107(3):796–802. https://doi.org/10.1016/j.fertnstert.2016.12.014 - DOI - PubMed
-
- Akgül S, Düzçeker Y, Kanbur N, Derman O (2018) Do different diagnostic criteria impact polycystic ovary syndrome diagnosis for adolescents? J Pediatr Adolesc Gynecol 31(3):258–262. https://doi.org/10.1016/j.jpag.2017.12.002 - DOI - PubMed
-
- Sirmans SM, Pate KA (2014) Epidemiology, diagnosis, and management of polycystic ovary syndrome. Clin Epidemiol 6:1–13. https://doi.org/10.2147/CLEP.S37559 - DOI
-
- Mohammad MB, Seghinsara AM (2017) Polycystic ovary syndrome (PCOS), diagnostic criteria, and AMH. Asian Pac J Cancer Prev 18(1):17–21. https://doi.org/10.22034/APJCP.2017.18.1.17 - DOI - PMC
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials